Zizimin2 (Ziz2), also known as dedicator of cytokinesis 11 (DOCK11), is a guanine nucleotide exchange factor that is predominantly expressed in lymphoid tissues. Recent findings demonstrated that Ziz2 is involved in the development of B cells, including germinal centre B cells and marginal zone B cells. However, limited information is currently available on the roles of Ziz2 in B-1 cells, a B-cell subset that resides in body cavities and contributes to protection against foreign pathogens in a T-cell-independent manner. We herein show that Ziz2 and its widely expressed isoform Ziz3 (also known as DOCK10) may be involved in defective production of anti-bacterial IgM by aged B-1a cells, a CD5+ subset of B-1 cells. Natural IgM against typical bacterial epitopes was defectively produced by peritoneal B-1a cells from aged mice. The down-regulation of Ziz2/3 in B-1a cells appeared to be responsible for this defective IgM production, as demonstrated by Ziz2/3 double-knockout mice. Mechanistically, lower levels of basal AKT phosphorylation did not allow for the differentiation of Ziz2/3-deficient B-1a cells into plasma cells. Defective production of anti-bacterial IgM was not fully rescued by immunization, resulting in slightly weaker protection in Ziz2/3-deficient mice. Thus, the down-regulation of Ziz2/3 in B-1a cells may at least partly account for defective protection in aged mice.

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxx054DOI Listing

Publication Analysis

Top Keywords

b-1a cells
24
cells
12
anti-bacterial igm
12
peritoneal b-1a
8
b-1 cells
8
defective production
8
production anti-bacterial
8
aged mice
8
mice down-regulation
8
down-regulation ziz2/3
8

Similar Publications

Sphingosine-1-phosphate receptor type 4 is critically involved in the regulation of peritoneal B-1 cell trafficking and distribution in vivo.

Eur J Immunol

December 2024

Experimental Surgical Research Laboratory, Department of General Surgery, Visceral, Thoracic and Vascular Surgery, Universitätsmedizin Greifswald, Greifswald, Germany.

B-1 cells are crucially involved in immune defense and regulation of inflammation and autoimmunity. B-1 cells are predominantly located in the peritoneal and pleural cavities, although body cavity B-1 cells recirculate systemically under steady-state conditions. The chemokines CXCL12 and CXCL13 have been identified as the main regulators of peritoneal B-cell trafficking.

View Article and Find Full Text PDF
Article Synopsis
  • Biomarkers are essential for detecting diseases like cancer early on, with CD5 being a key protein linked to immune regulation and various diseases.
  • A new electrochemical immunosensor using advanced Ti/Au electrodes allows for ultra-sensitive detection of CD5 in blood serum, surpassing current methods.
  • This sensor demonstrates impressive sensitivity, with detection limits far better than traditional ELISA kits, showing promise for enhancing early cancer diagnosis and other medical uses.
View Article and Find Full Text PDF

During the perinatal period, the immune system sets the threshold to select either response or tolerance to environmental Ags, which leads to the potential to provide a lifetime of protection and health. B-1a B cells have been demonstrated to develop during this perinatal time window, showing a unique and restricted BCR repertoire, and these cells play a major role in natural Ab secretion and immune regulation. In the current study, we developed a highly efficient temporally controllable RAG2-based lymphoid lineage cell labeling and tracking system and applied this system to understand the biological properties and contribution of B-1a cells generated at distinct developmental periods to the adult B-1a compartments.

View Article and Find Full Text PDF
Article Synopsis
  • B-1a cells help fight infections and control swelling by releasing special proteins.
  • In sepsis, these cells move to the spleen, changing their abilities, which can cause problems.
  • A protein called Siglec-G helps keep B-1a cells in place, but in sepsis, a substance from neutrophils can break it down, and scientists found a special decoy that can protect Siglec-G and help B-1a cells stay healthier.
View Article and Find Full Text PDF

Post-transcriptional (re)programming of B lymphocyte development: From bench to bedside?

Adv Immunol

May 2024

Integrative Immunobiology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States. Electronic address:

Article Synopsis
  • Hematopoiesis is the process of producing blood and immune cells, which undergo significant changes from fetal development to adulthood, especially marked by the formation of long-term hematopoietic stem cells (HSCs).
  • This text examines the post-transcriptional differences between fetal liver HSCs and adult bone marrow HSCs, exploring how certain RNA-binding proteins can reprogram adult HSCs to resemble their fetal counterparts.
  • Specifically, it highlights the role of LIN28B and IGF2BP3 in promoting the development of particular immune cells, proposing potential clinical applications, such as in utero HSC transplantation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!